Baird served as a co-manager in this offering.
AboutDanaher Corporation (NYSE:DHR) (“Danaher” or the “Company”) recently completed a follow-on offering of 17,500,000 shares of common stock, par value $0.01 per share, at a price to the public of $51.75 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 1,750,000 shares of common stock. Danaher expects to receive net proceeds, after expenses and the underwriters’ discount and assuming the underwriters’ option is not exercised, of approximately $877.4 million. The Company anticipates using the net proceeds from the offering to pay a portion of the purchase price of the previously announced acquisition of Beckman Coulter, Inc. and for general corporate purposes if any proceeds remain or if the proposed acquisition does not close.
Danaher is a diversified technology leader that designs, manufactures and offers innovative products and services to professional, medical, industrial and commercial customers through research and development, manufacturing, sales, distribution, service and administrative facilities located in more than 50 countries. The Company’s business operations consist of five primary reporting segments, including: Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial Technologies. Danaher’s 48,000 associates serve customers in more than 125 countries.
For additional information about this transaction, please contact:
- June 2011
- Danaher Corporation
- Target Location
- North America